$IBTA

Lehrman Thomas D sold $595K of IBTA

Lehrman Thomas D sold 15,926 shares of Ibotta, Inc. (IBTA) at an average of $37.37 ($37.19–$37.98, $0.60M total) across 2 trades on 2026-08-13.

Original reporting
SEC EDGAR · Lehrman Thomas D
Published Aug 17, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 17, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBTA
Neutral
low confidence
Mentioned
$IBTA
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBTANeutralLow
01

Why it matters

The newest information is the specific sale transaction details (shares, dates, price range, and post-transaction holdings). It does not include any company performance or forward-looking statements.

02

Market read

Traders may note the insider sale as a minor sentiment datapoint, but there is no fundamental catalyst in the text.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; without additional context, the signal is weak.

Relevance 5/10Novelty 3/10Timing: Form 4 filed Aug. 17, covering sales executed Aug. 13.

Background

The article is a SEC Form 4 insider transaction disclosure for Ibotta, Inc. (IBTA).

Company-level read

Ticker impact

$IBTANeutralLow confidence
Context

Ibotta director Lehrman Thomas D sold about 15,926 shares in open-market transactions totaling $595,182.86, per a new Form 4 filed Aug. 17.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven and typically fades unless accompanied by other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction. The article provides sale size, dates, and price range, but no earnings, guidance, legal, or operational catalyst that would reset valuation expectations.

Market effects

No clear sector read-through from a single director open-market sale disclosure.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.

Key entities

  • Ibotta, Inc.

    Public company subject of the Form 4 insider sale disclosure.

  • Lehrman Thomas D

    Director who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IBTAMedAI 8/10

Ibotta (IBTA) Q2 2026 Earnings Call Transcript

Ibotta (IBTA) reported Q2 2026 revenue of $88.9 million, up 3% year over year, and adjusted EBITDA of $16.5 million. Third-party redemption revenue rose 27% to $61.5 million as the company shifted users to its publisher network. Q3 revenue guidance is $86 million to $90 million. Ibotta also said it added 11,500 7-Eleven locations via a partnership.

$IBTAMed

Ibotta, Inc. (IBTA): Results of Operations and Financial Condition

Ibotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million Redemption revenue grew by 10% year-over-year to $80